586-39-0 | Sigma-Aldrich

Aldrich Polymer Products Application - Poss

T.L. J. Am. Chem.Soc. 1994,116, 2145. (10) Edelman, F.T. Angew. Chem. Int. Ed. Engl. 1992, 31, 586. (11) Feher, F.J. et al. J. Am. Chem. Soc. 1991, 113, 3618. (12) Feher, F.J. et al. ibid. 1986

Quantitative PCR Product Listing

R O r d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 T e c h n i c a l S e r v

Report: The changing Biopharma risk equation

row. (% respondents) 49 35 16 49 38 13 39 37 24 49 34 17 47 32 21 34 44 22 34 40 26

sFasL, IL-33 (pg/mL) Standard 1 37 1.7 0.3 20 Standard 2 146 6.8 1.1 78 Standard 3 586 27 4.3 313 Standard 4 2,344 109 17 1,250 Standard

User Guide-HCYTB60K

sFasL, IL-33 (pg/mL) Standard 1 37 1.7 0.3 20 Standard 2 146 6.8 1.1 78 Standard 3 586 27 4.3 313 Standard 4 2,344 109 17 1,250 Standard

User Guide

sFasL, IL-33 (pg/mL) Standard 1 37 1.7 0.3 20 Standard 2 146 6.8 1.1 78 Standard 3 586 27 4.3 313 Standard 4 2,344 109 17 1,250 Standard

Protocol- PRCYTA-40K|PRCYTA-40K-PX38|PRCYTA-40K-BK38|PRCYTA-40K-PX48|PRCYTA-40K-BK48

TNFα (pg/mL) Standard 1 24.41 2.44 36.62 4.88 Standard 2 98 9.77 146 20 Standard 3 391 39 586 78 Standard 4 1,563 156 2,344 313 Standard 5 6,250 625

hKir2.1-HEK293 Recombinant Cell Line

Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels Pharmacol Rev 55(4), 583-586 Hume, J. R. and Uehara, A. (1985) Ionic basis of the different action potential configurations

Protocol- EQCYTMAG-93K

, IL-8 (pg/mL) GM-CSF, RANTES (pg/mL) Fractalkine (pg/mL) Standard 1 59 5 586 Standard 2 234 20 2,344 Standard 3 938 78 9,375

Protocol- HBNMAG-51K

(pg/mL) IL-1β (pg/mL) FGF23 (pg/mL) Standard 1 146 98 24 1 9 Standard 2 586 391 98 3 37 Standard 3 2,344 1,563 391 12 146

Protocol: Human Bone Magnetic Bead Panel

(pg/mL) IL-1 (pg/mL) FGF23 (pg/mL) Standard 1 146 98 24 1 9 Standard 2 586 391 98 3 37 Standard 3 2,344 1,563 391 12 146

Non-Human Primate Cytokine/Chemokine/Growth Factor Panel A Magnetic Bead Panel

(pg/mL) Standard 1 24.41 2.44 36.62 4.88 Standard 2 98 9.77 146 20 Standard 3 391 39 586 78 Standard 4 1,563 156 2,344 313 Standard 5 6,250 625 9,375

Protocol- PRCYT2MAG40K, PRCYTMAG40K-PX24, PRCYTMAG40K-PX25, PRCY2MG40PMX24BK, PRCY2MG40PMX25BK

IL-6 (pg/mL) IL-17E/IL-25 (pg/mL) Standard 1 15 146 24 3 293 Standard 2 59 586 98 12 1172 Standard 3 234 2344 391 47 4688 Standard

Protocol- MTH17MAG-47K|MT17MAG47K-PX25|MT17MAG47PMX25BK

MIP-3α, IL-31 & CD40L (pg/mL) IL-1β (pg/mL) IL-2 (pg/mL) Standard 1 586 34 7.8 49 15 6.9 Standard 2 2344 137 31.3 195

Protocol- HCKP2-11K

6.10 36.6 366 61.0 2.44 Standard 2 73.2 5 24.4 146.5 1465 244 9.77 Standard 3 293 20 97.7 586 5859 977 39.1 Standard 4 1,172 78 391 2,344 23,438 3,906 156

Human Immuno-Oncology Checkpoint Protein Panel 2

6.10 36.6 366 61.0 2.44 Standard 2 73.2 5 24.4 146.5 1465 244 9.77 Standard 3 293 20 97.7 586 5859 977 39.1 Standard 4 1,172 78 391 2,344 23,438 3,906 156

Fast and Precise. Thin Layer Chromatography by.

trichloroacetic acid dioxane sol. ammonia in 1 l water; 70/30 Migration distance 7 cm Detection 586 nm (TLC/HPTLC Scanner, Camag) 16 Cellulose plates (TLC and HPTLC) Packing Material

JAK/STAT Signaling Research Focus

B, H, M, R, Sh WB 100 µg 05-495 Anti-phospho-STAT5A/B (Tyr694/699) B, H, M, R DB, WB 100 µL 07-586 Anti-phospho-STAT5A/B (Tyr694/699), clone A11W B, Chp, H, M, R WB (Not IP) 100 µL 04-886

Protocol- MBNMAG-41K

Leptin (pg/mL) SOST & TNF-α (pg/mL) Standard 1 37 10 3 Standard 2 146 39 12 Standard 3 586 156 47 Standard 4 2,344 625 188

Protocol: Mouse Bone Magnetic Bead Panel --96-Well Plate Assay

Leptin (pg/mL) SOST & TNF-α (pg/mL) Standard 1 37 10 3 Standard 2 146 39 12 Standard 3 586 156 47 Standard 4 2,344 625

Integration of Experimental and Computational Microfluidics in 3D Tissue Engineering

al., “Study of Osteoblastic Cells in a Microfluidic Environment,” Biomaterials, Vol. 27, 2006, pp. 586–595. [20] Wu, H. W., et al., “The Culture and Differentiation of Amniotic Stem Cells Using a Microfluidic

Chicken Cytokine/Chemokine Panel

1 7.32 3.66 18.3 24.4 36.6 48.8 Standard 2 29 14.6 73 98 147 195 Standard 3 117 59 293 391 586 781 Standard 4 469 234 1,172 1,563 2,344 3,125 Standard

Antibody SourceBook, Sixth Edition, DIST version

-Terminal (385-39�) Rabbit pAb IB mammalian 371732 50 µl €�13 Anti-Gsa-Subunit Rabbit pAb ELISA, IB 371731 50 µl €390 Anti-Gta-1-Subunit Mouse mAb (TF15) ELISA, IB mammalian 3717�0 100 µl €390

Protocol- GCYT1-16K|GCYT1-16K-PX12|GCYT1-16K-PXBK12

1 7.32 3.66 18.3 24.4 36.6 48.8 Standard 2 29 14.6 73 98 147 195 Standard 3 117 59 293 391 586 781 Standard 4 469 234 1,172 1,563 2,344 3,125 Standard

Organic and Molecular Electronics

.70 BSB-Me 505 92±3 1.0 9.1 0.78±0.10 2.66 BSB-OMe 530 90±1 1.2 7.2 0.90±0.10 2.33 BSB-CN 586 55±2 1.5 3.7 2.35±0.10 1.84 The ASE thresholds are not directly correlated with φf or τf but are

Chrombook (WEB-Version)

Hunter Boulevard, Magna Park, Lutterworth LEICESTERSHIRE LE17 4 XN Phone +44 (0) 800 223 344 Telefax +44 (0) 1455 558 586 E-mail uksales@uk.vwr.com Internet https://uk.vwr.com CHEMICALS FOR PRODUCTION

Inhibitor Sourcebook 3rd Edition

............................39 475815 ..............................................................39 475816 ..............................................................39 475818 ....................

XP725 Antibody List 013M4793

25023 Prkcb1 NP_036845.2 M n/d n/d y 585 Protein Kinase Cγ P8083 24681 Prkcc NP_036760.1 M n/d n/d y 586 Protein Kinase Cδ P8333 170538 Prkcd NP_579841.1 P n/d n/d y 587 Protein Kinase Cε P8458 29340 Prkce

XP725 Antibody List

25023 Prkcb1 NP_036845.2 M n/d n/d y 585 Protein Kinase Cγ P8083 24681 Prkcc NP_036760.1 M n/d n/d y 586 Protein Kinase Cδ P8333 170538 Prkcd NP_579841.1 P n/d n/d y 587 Protein Kinase Cε P8458 29340 Prkce

Cytoskeletal Signaling Antibodies, Reagents and Kits

Assay 20-196 Ral Activation Assay Buffer, 5X 14-415 Ral Assay Reagent (RAL BP1, Agarose) 05-586 anti-RalA 04-037 anti-RalB, clone 25 21-189 RalA cDNA (active) 21-187 RalA cDNA (dominant